AGL 38.31 Decreased By ▼ -0.52 (-1.34%)
AIRLINK 141.40 Decreased By ▼ -2.00 (-1.39%)
BOP 5.64 Increased By ▲ 0.40 (7.63%)
CNERGY 3.87 Increased By ▲ 0.15 (4.03%)
DCL 7.56 Decreased By ▼ -0.02 (-0.26%)
DFML 47.40 Increased By ▲ 1.00 (2.16%)
DGKC 79.75 Decreased By ▼ -1.13 (-1.4%)
FCCL 27.44 Increased By ▲ 0.02 (0.07%)
FFBL 54.85 Decreased By ▼ -0.15 (-0.27%)
FFL 8.60 Increased By ▲ 0.04 (0.47%)
HUBC 113.51 Increased By ▲ 2.49 (2.24%)
HUMNL 11.20 Decreased By ▼ -0.22 (-1.93%)
KEL 3.99 Increased By ▲ 0.22 (5.84%)
KOSM 8.54 Increased By ▲ 0.21 (2.52%)
MLCF 35.00 Decreased By ▼ -0.20 (-0.57%)
NBP 63.80 Increased By ▲ 2.45 (3.99%)
OGDC 169.40 Decreased By ▼ -2.50 (-1.45%)
PAEL 25.18 Decreased By ▼ -0.60 (-2.33%)
PIBTL 5.89 Decreased By ▼ -0.08 (-1.34%)
PPL 125.75 Decreased By ▼ -1.80 (-1.41%)
PRL 24.79 Decreased By ▼ -0.79 (-3.09%)
PTC 13.26 Increased By ▲ 1.11 (9.14%)
SEARL 57.45 Increased By ▲ 0.45 (0.79%)
TELE 7.12 Increased By ▲ 0.02 (0.28%)
TOMCL 35.00 Increased By ▲ 0.20 (0.57%)
TPLP 7.45 Increased By ▲ 0.50 (7.19%)
TREET 14.32 Increased By ▲ 0.47 (3.39%)
TRG 46.54 Decreased By ▼ -0.51 (-1.08%)
UNITY 26.18 Increased By ▲ 0.13 (0.5%)
WTL 1.20 Decreased By ▼ -0.01 (-0.83%)
BR100 9,091 Decreased By -2.4 (-0.03%)
BR30 27,347 Increased By 28.9 (0.11%)
KSE100 85,669 Increased By 5.3 (0.01%)
KSE30 27,216 Decreased By -224.9 (-0.82%)

WASHINGTON: The United States on Monday withdrew emergency use authorisations for two coronavirus treatments favoured by President Donald Trump, citing their lack of efficacy and safety concerns.

"It is no longer reasonable to believe that oral formulations of HCQ (hydroxychloroquine) and CQ (chloroquine) may be effective in treating Covid-19," Denise Hinton, chief scientist of the Food and Drug Administration (FDA) wrote in a letter.

She added: "Nor is it reasonable to believe that the known and potential benefits of these products outweigh their known and potential risk. "Accordingly, FDA revokes the EUA for emergency use of HCQ and CQ to treat Covid-19."

Copyright Agence France-Presse, 2020

Comments

Comments are closed.